These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 14598562

  • 1. AIDS vaccine development: the long and winding road.
    Garber DA, Feinberg MB.
    AIDS Rev; 2003; 5(3):131-9. PubMed ID: 14598562
    [Abstract] [Full Text] [Related]

  • 2. Heterologous prime-boost vaccination strategies for HIV-1: augmenting cellular immune responses.
    Newman MJ.
    Curr Opin Investig Drugs; 2002 Mar; 3(3):374-8. PubMed ID: 12054082
    [Abstract] [Full Text] [Related]

  • 3. HIV/AIDS vaccines: 2007.
    Robinson HL.
    Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
    [Abstract] [Full Text] [Related]

  • 4. Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1.
    Paris RM, Kim JH, Robb ML, Michael NL.
    Expert Rev Vaccines; 2010 Sep; 9(9):1055-69. PubMed ID: 20822348
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
    Rollman E, Mathy N, Bråve A, Boberg A, Kjerrström A, van Wely C, Engström G, Johansson S, Aperia K, Eriksson LE, Benthin R, Ertl P, Heeney J, Hinkula J, Voss G, Wahren B.
    Vaccine; 2007 Mar 01; 25(11):2145-54. PubMed ID: 17254672
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Progress and obstacles in the development of an AIDS vaccine.
    Letvin NL.
    Nat Rev Immunol; 2006 Dec 01; 6(12):930-9. PubMed ID: 17124514
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preclinical evaluation of cellular immune responses elicited by a polyvalent DNA prime/protein boost HIV-1 vaccine.
    Cristillo AD, Wang S, Caskey MS, Unangst T, Hocker L, He L, Hudacik L, Whitney S, Keen T, Chou TH, Shen S, Joshi S, Kalyanaraman VS, Nair B, Markham P, Lu S, Pal R.
    Virology; 2006 Mar 01; 346(1):151-68. PubMed ID: 16325880
    [Abstract] [Full Text] [Related]

  • 13. [The quest for an HIV vaccine].
    Girard MP.
    Bull Acad Natl Med; 2005 May 01; 189(5):831-44; discussion 844. PubMed ID: 16433455
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Narrowed TCR diversity for immunised mice challenged with recombinant influenza A-HIV Env(311-320) virus.
    Cukalac T, Moffat JM, Venturi V, Davenport MP, Doherty PC, Turner SJ, Stambas J.
    Vaccine; 2009 Nov 12; 27(48):6755-61. PubMed ID: 19744584
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Novel vaccines against M. tuberculosis].
    Okada M.
    Kekkaku; 2006 Dec 12; 81(12):745-51. PubMed ID: 17240920
    [Abstract] [Full Text] [Related]

  • 18. Functional CD8+ CTLs in mucosal sites and HIV infection: moving forward toward a mucosal AIDS vaccine.
    Belyakov IM, Ahlers JD.
    Trends Immunol; 2008 Nov 12; 29(11):574-85. PubMed ID: 18838298
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.